FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2190-2191 November 17, 2005 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Watanabe, D. PubMed Citation

To the Editor: Watanabe et al. (Aug. 25 issue)¹ reported on erythropoietin as a factor inducing retinal angiogenesis in proliferative diabetic retinopathy independently of vascular endothelial growth factor. Preterm infants are at high risk for retinopathy of prematurity — a multifactorial, severe, vasoproliferative retinal disorder — and they often undergo treatment with erythropoietin for the prevention of anemia of prematurity.

In our tertiary neonatal intensive care unit in a high-income urban area in northern Italy, data on 695 neonates with birth weights of less than 1500 g who were admitted between 1997 and 2004 showed that erythropoietin is an additional, . . . [Full Text of this Article]

This article has been cited by other articles:

• Zhang, J., Wu, Y., Jin, Y., Ji, F., Sinclair, S. H., Luo, Y., Xu, G., Lu, L., Dai, W., Yanoff, M., Li, W., Xu, G.-T. (2008). Intravitreal Injection of Erythropoietin Protects both Retinal Vascular and Neuronal Cells in Early Diabetes. IOVS 49: 732-742 [Abstract] [Full Text]  
• Westenbrink, B. D., Lipsic, E., van der Meer, P., van der Harst, P., Oeseburg, H., Du Marchie Sarvaas, G. J., Koster, J., Voors, A. A., van Veldhuisen, D. J., van Gilst, W. H., Schoemaker, R. G. (2007). Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 28: 2018-2027 [Abstract] [Full Text]